Novel ADAMTS13 mutations in an obstetric patient with upshaw-schulman syndrome

Deal, Taylor; Kremer Hovinga, Johanna A.; Marques, Marisa B.; Adamski, Jill (2013). Novel ADAMTS13 mutations in an obstetric patient with upshaw-schulman syndrome. Journal of clinical apheresis, 28(4), pp. 311-316. New York, N.Y.: Wiley-Liss 10.1002/jca.21251

[img] Text
OA043 Deal T J Clin Aph 2013.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (208kB) | Request a copy

Upshaw-Schulman syndrome (USS) is a rarely reported congenital form of thrombotic thrombocytopenic purpura (TTP) that results from mutations in the ADAMTS13 gene. Many USS patients are diagnosed during the second or third trimester of their first pregnancy. We present a patient diagnosed with USS following retinal detachments and intrauterine fetal demise at 34 weeks of gestation. The patient's plasma was tested for ADAMTS13 activity, inhibitor, and antibody. Subsequently, she and her first-degree relatives had ADAMTS13 gene sequencing. Initially, the patient was found to have an ADAMTS13 activity of <5% in the absence of an ADAMTS13 inhibitor (FRETS assay) or antibody (immunoassay). Repeat studies in the months following hospital discharge showed persistent, undetectable ADAMTS13 activity and she was given a clinical diagnosis of USS. Molecular sequencing demonstrated two novel missense mutations in the ADAMTS13 gene: one in the maternal exon 17 (p.Ala690Thr due to nucleotide substitution c.2068 G>A) and another in the paternal exon 22 (p.Arg915Cys due to nucleotide substitution c.2746 C>T). In addition to being compound heterozygous for two ADAMTS13 mutations, the patient also had two maternally inherited single nucleotide polymorphisms: p.P618A (exon 16) and p.A732V (exon 18). Her parents and only sister had normal or near-normal ADAMTS13 activity. Each was heterozygous for one of the novel missense mutations. This case highlights the importance of molecular analysis of the ADAMTS13 gene in patients and family members when the severe ADAMTS13 deficiency does not appear to be autoimmune in nature. J. Clin. Apheresis, 2012. © 2012 Wiley Periodicals, Inc.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory

UniBE Contributor:

Kremer Hovinga, Johanna Anna

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0733-2459

Publisher:

Wiley-Liss

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:32

Last Modified:

26 Nov 2015 09:50

Publisher DOI:

10.1002/jca.21251

PubMed ID:

23208954

Web of Science ID:

000322921600005

BORIS DOI:

10.7892/boris.12592

URI:

https://boris.unibe.ch/id/eprint/12592 (FactScience: 218954)

Actions (login required)

Edit item Edit item
Provide Feedback